Experimental Models of Inflammatory Bowel Diseases

Hermiston, 1995, Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin, Science, 270, 1203, 10.1126/science.270.5239.1203 Okayasu, 1990, A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology, 98, 694, 10.1016/0016-5085(90)90290-H Cooper, 1993, Clinicopathologic study of dextran sulfate sodium experimental murine colitis, Lab Invest, 69, 238 Dieleman, 1994, Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice, Gastroenterology, 107, 1643, 10.1016/0016-5085(94)90803-6 Krieglstein, 2002, Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis, J Clin Invest, 110, 1773, 10.1172/JCI200215256 Fukata, 2005, Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis, Am J Physiol Gastrointest Liver Physiol, 288, G1055, 10.1152/ajpgi.00328.2004 Pull, 2005, Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury, Proc Natl Acad Sci USA, 102, 99, 10.1073/pnas.0405979102 Dieleman, 1998, Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by TH1 and Th2 cytokines, Clin Exp Immunol, 114, 385, 10.1046/j.1365-2249.1998.00728.x Chami, 2014, The role of CXCR3 in DSS-induced colitis, PLoS One, 9, e101622, 10.1371/journal.pone.0101622 Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002 Cario, 2007, Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function, Gastroenterology, 132, 1359, 10.1053/j.gastro.2007.02.056 Iliev, 2012, Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis, Science, 336, 1314, 10.1126/science.1221789 Dupaul-Chicoine, 2010, Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases, Immunity, 32, 367, 10.1016/j.immuni.2010.02.012 Zaki, 2010, The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis, Immunity, 32, 379, 10.1016/j.immuni.2010.03.003 Elinav, 2011, NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis, Cell, 145, 745, 10.1016/j.cell.2011.04.022 Sokol, 2013, Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice, Gastroenterology, 145, 591, 10.1053/j.gastro.2013.05.047 Hsu, 2010, Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury, Lab Invest, 90, 1295, 10.1038/labinvest.2010.100 Egea, 2013, GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa, J Immunol, 190, 1702, 10.4049/jimmunol.1202368 Sedhom, 2013, Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice, Gut, 62, 1714, 10.1136/gutjnl-2011-301785 Koch, 2011, The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair, Gastroenterology, 141, 259, 10.1053/j.gastro.2011.03.043 Siegmund, 2001, IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation, Proc Natl Acad Sci USA, 98, 13249, 10.1073/pnas.231473998 Maeda, 2005, Nod2 mutation in Crohn’s disease potentiates NF-κB activity and IL-1β processing, Science, 307, 734, 10.1126/science.1103685 Saitoh, 2008, Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production, Nature, 456, 264, 10.1038/nature07383 Bersudsky, 2014, Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice, Gut, 63, 598, 10.1136/gutjnl-2012-303329 Siegmund, 2001, Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production, Am J Physiol Regul Integr Comp Physiol, 281, R1264, 10.1152/ajpregu.2001.281.4.R1264 Sivakumar, 2002, Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage, Gut, 50, 812, 10.1136/gut.50.6.812 Takagi, 2003, Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice, Scand J Gastroenterol, 38, 837, 10.1080/00365520310004047 Reuter, 2004, Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?, Eur J Immunol, 34, 2347, 10.1002/eji.200425351 Salcedo, 2010, MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18, J Exp Med, 207, 1625, 10.1084/jem.20100199 Huber, 2012, IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine, Nature, 491, 259, 10.1038/nature11535 Rutter, 2004, Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, 126, 451, 10.1053/j.gastro.2003.11.010 Jess, 2006, Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota, Gastroenterology, 130, 1039, 10.1053/j.gastro.2005.12.037 Gupta, 2007, Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study, Gastroenterology, 133, 1099, 10.1053/j.gastro.2007.08.001 Tanaka, 2003, A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate, Cancer Sci, 94, 965, 10.1111/j.1349-7006.2003.tb01386.x Wang, 2014, Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis, Mucosal Immunol, 7, 1106, 10.1038/mi.2013.126 Natividad, 2012, Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1−/−; Nod2−/− mice, Inflamm Bowel Dis, 18, 1434, 10.1002/ibd.22848 Chen, 2011, A functional role for Nlrp6 in intestinal inflammation and tumorigenesis, J Immunol, 186, 7187, 10.4049/jimmunol.1100412 Normand, 2011, Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury, Proc Natl Acad Sci USA, 108, 9601, 10.1073/pnas.1100981108 Hu, 2013, Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer, Proc Natl Acad Sci USA, 110, 9862, 10.1073/pnas.1307575110 Neurath, 2000, TNBS-colitis, Int Rev Immunol, 19, 51, 10.3109/08830180009048389 Neurath, 1995, Antibodies to interleukin 12 abrogate established experimental colitis in mice, J Exp Med, 182, 1281, 10.1084/jem.182.5.1281 Strober, 2011, Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases, Gastroenterology, 140, 1756, 10.1053/j.gastro.2011.02.016 Davidson, 1998, IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice, J Immunol, 161, 3143, 10.4049/jimmunol.161.6.3143 Simpson, 1998, T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells, J Exp Med, 187, 1225, 10.1084/jem.187.8.1225 Mannon, 2004, Anti-interleukin-12 antibody for active Crohn’s disease, N Engl J Med, 351, 2069, 10.1056/NEJMoa033402 Sandborn, 2008, Ustekinumab Crohn’s Disease Study G. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease, Gastroenterology, 135, 1130, 10.1053/j.gastro.2008.07.014 Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 Becker, 2006, Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis, J Immunol, 177, 2760, 10.4049/jimmunol.177.5.2760 Hue, 2006, Interleukin-23 drives innate and T cell-mediated intestinal inflammation, J Exp Med, 203, 2473, 10.1084/jem.20061099 O’Connor, 2009, A protective function for interleukin 17A in T cell-mediated intestinal inflammation, Nat Immunol, 10, 603, 10.1038/ni.1736 Meylan, 2011, The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation, Mucosal Immunol, 4, 172, 10.1038/mi.2010.67 Dohi, 1999, Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses, J Exp Med, 189, 1169, 10.1084/jem.189.8.1169 Dohi, 2000, Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis, Gastroenterology, 119, 724, 10.1053/gast.2000.16500 Fichtner-Feigl, 2005, Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides, J Clin Invest, 115, 3057, 10.1172/JCI24792 Lawrance, 2003, A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B, Gastroenterology, 125, 1750, 10.1053/j.gastro.2003.08.027 Fichtner-Feigl, 2008, IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis, Gastroenterology, 135, 2003, 10.1053/j.gastro.2008.08.055 Koon, 2010, Substance P modulates colitis-associated fibrosis, Am J Pathol, 177, 2300, 10.2353/ajpath.2010.100314 Yoo, 2015, Antifibrogenic effects of the antimicrobial peptide cathelicidin in murine colitis-associated fibrosis, Cell Mol Gastroenterol Hepatol, 1, 55, 10.1016/j.jcmgh.2014.08.001 Shih, 2014, Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis, Mucosal Immunol, 7, 1492, 10.1038/mi.2014.37 Fichtner-Feigl, 2014, IL-13 orchestrates resolution of chronic intestinal inflammation via phosphorylation of glycogen synthase kinase-3β, J Immunol, 192, 3969, 10.4049/jimmunol.1301072 Fiorucci, 2002, Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis, Immunity, 17, 769, 10.1016/S1074-7613(02)00476-4 Watanabe, 2014, NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6, Mucosal Immunol, 7, 1312, 10.1038/mi.2014.19 Boirivant, 2008, A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis, Gastroenterology, 135, 1612, 10.1053/j.gastro.2008.07.028 Girardin, 2003, Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection, J Biol Chem, 278, 8869, 10.1074/jbc.C200651200 Amendola, 2014, Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms, Mucosal Immunol, 7, 391, 10.1038/mi.2013.58 Neurath, 1996, Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance, J Exp Med, 183, 2605, 10.1084/jem.183.6.2605 Fuss, 2002, The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis, J Immunol, 168, 900, 10.4049/jimmunol.168.2.900 Boirivant, 2005, Regulatory cells induced by feeding TNP-haptenated colonic protein cross-protect mice from colitis induced by an unrelated hapten, Inflamm Bowel Dis, 11, 48, 10.1097/00054725-200501000-00007 Boirivant, 1998, Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4, J Exp Med, 188, 1929, 10.1084/jem.188.10.1929 Heller, 2002, Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells, Immunity, 17, 629, 10.1016/S1074-7613(02)00453-3 Olszak, 2012, Microbial exposure during early life has persistent effects on natural killer T cell function, Science, 336, 489, 10.1126/science.1219328 Fuss, 2004, Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis, J Clin Invest, 113, 1490, 10.1172/JCI19836 Heller, 2005, Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, Gastroenterology, 129, 550, 10.1016/j.gastro.2005.05.002 Dohi, 2009, TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis, Gastroenterology, 136, 912, 10.1053/j.gastro.2008.11.017 Kawashima, 2011, Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis, Gastroenterology, 141, 2119, 10.1053/j.gastro.2011.08.040 Krug, 2014, Impaired epithelial barrier for macromolecules in ulcerative colitis is caused by downregulation of the tricellular tight junction protein tricellulin, mediated by the interleukin-13 receptor α2-activated pathway. [Abstract 410.], Gasteroenterology, 146, S88, 10.1016/S0016-5085(14)60318-8 Weber, 2010, Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity, J Biol Chem, 285, 12037, 10.1074/jbc.M109.064808 Gerlach, 2014, TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells, Nat Immunol, 15, 676, 10.1038/ni.2920 Camelo, 2012, Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13, J Gastroenterol, 47, 1198, 10.1007/s00535-012-0591-2 Fuss, 2014, IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis, Gut, 63, 1728, 10.1136/gutjnl-2013-305671 Powrie, 1993, Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice, Int Immunol, 5, 1461, 10.1093/intimm/5.11.1461 Powrie, 1994, Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells, Immunity, 1, 553, 10.1016/1074-7613(94)90045-0 Read, 2000, Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation, J Exp Med, 192, 295, 10.1084/jem.192.2.295 Leach, 1996, Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells, Am J Pathol, 148, 1503 Vignali, 2008, How regulatory T cells work, Nat Rev Immunol, 8, 523, 10.1038/nri2343 Shevach, 2009, Mechanisms of foxp3+ T regulatory cell-mediated suppression, Immunity, 30, 636, 10.1016/j.immuni.2009.04.010 Asseman, 1999, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation, J Exp Med, 190, 995, 10.1084/jem.190.7.995 Davidson, 1996, T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice, J Exp Med, 184, 241, 10.1084/jem.184.1.241 Murai, 2009, Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis, Nat Immunol, 10, 1178, 10.1038/ni.1791 Powrie, 1996, A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells, J Exp Med, 183, 2669, 10.1084/jem.183.6.2669 Nakamura, 2001, Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J Exp Med, 194, 629, 10.1084/jem.194.5.629 Nakamura, 2004, TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice, J Immunol, 172, 834, 10.4049/jimmunol.172.2.834 Fahlen, 2005, T cells that cannot respond to TGF-beta escape control by CD4+CD25+ regulatory T cells, J Exp Med, 201, 737, 10.1084/jem.20040685 Neurath, 2002, The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease, J Exp Med, 195, 1129, 10.1084/jem.20011956 Ahern, 2010, Interleukin-23 drives intestinal inflammation through direct activity on T cells, Immunity, 33, 279, 10.1016/j.immuni.2010.08.010 Elson, 2007, Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice, Gastroenterology, 132, 2359, 10.1053/j.gastro.2007.03.104 Leppkes, 2009, RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F, Gastroenterology, 136, 257, 10.1053/j.gastro.2008.10.018 Mikami, 2010, Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis, Eur J Immunol, 40, 2409, 10.1002/eji.201040379 Griseri, 2010, OX40 is required for regulatory T cell-mediated control of colitis, J Exp Med, 207, 699, 10.1084/jem.20091618 Sakuraba, 2009, Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn’s disease, Gastroenterology, 137, 1736, 10.1053/j.gastro.2009.07.049 Sujino, 2011, Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells, Gastroenterology, 141, 1014, 10.1053/j.gastro.2011.05.052 Lee, 2009, Late developmental plasticity in the T helper 17 lineage, Immunity, 30, 92, 10.1016/j.immuni.2008.11.005 Izcue, 2008, Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis, Immunity, 28, 559, 10.1016/j.immuni.2008.02.019 Schiering, 2014, The alarmin IL-33 promotes regulatory T-cell function in the intestine, Nature, 513, 564, 10.1038/nature13577 Wang, 2011, An essential role of the transcription factor GATA-3 for the function of regulatory T cells, Immunity, 35, 337, 10.1016/j.immuni.2011.08.012 Wohlfert, 2011, GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice, J Clin Invest, 121, 4503, 10.1172/JCI57456 Beltran, 2010, Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease, Inflamm Bowel Dis, 16, 1097, 10.1002/ibd.21175 Kobori, 2010, Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis, J Gastroenterol, 45, 999, 10.1007/s00535-010-0245-1 Palmer, 2011, Interleukin-33 biology with potential insights into human diseases, Nat Rev Rheumatol, 7, 321, 10.1038/nrrheum.2011.53 Pastorelli, 2010, Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis, Proc Natl Acad Sci U S A, 107, 8017, 10.1073/pnas.0912678107 Seidelin, 2010, IL-33 is upregulated in colonocytes of ulcerative colitis, Immunol Lett, 128, 80, 10.1016/j.imlet.2009.11.001 Veldhoen, 2006, TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001 Zhou, 2007, IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nat Immunol, 8, 967, 10.1038/ni1488 Ghoreschi, 2010, Generation of pathogenic TH17 cells in the absence of TGF-beta signalling, Nature, 467, 967, 10.1038/nature09447 McGeachy, 2007, TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology, Nat Immunol, 8, 1390, 10.1038/ni1539 Lee, 2012, Induction and molecular signature of pathogenic TH17 cells, Nat Immunol, 13, 991, 10.1038/ni.2416 Griseri, 2012, Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation, Immunity, 37, 1116, 10.1016/j.immuni.2012.08.025 Buonocore, 2010, Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology, Nature, 464, 1371, 10.1038/nature08949 Geremia, 2011, IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease, J Exp Med, 208, 1127, 10.1084/jem.20101712 Dianda, 1997, T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment, Am J Pathol, 150, 91 Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, 66, 5224, 10.1128/IAI.66.11.5224-5231.1998 Garrett, 2007, Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system, Cell, 131, 33, 10.1016/j.cell.2007.08.017 Schultz, 1999, IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation, Am J Physiol, 276, G1461 Aranda, 1997, Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients, J Immunol, 158, 3464, 10.4049/jimmunol.158.7.3464 Palm, 2014, Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease, Cell, 158, 1000, 10.1016/j.cell.2014.08.006 Mazmanian, 2008, A microbial symbiosis factor prevents intestinal inflammatory disease, Nature, 453, 620, 10.1038/nature07008 Round, 2010, Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota, Proc Natl Acad Sci USA, 107, 12204, 10.1073/pnas.0909122107 Atarashi, 2011, Induction of colonic regulatory T cells by indigenous Clostridium species, Science, 331, 337, 10.1126/science.1198469 Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature, 504, 451, 10.1038/nature12726 Lord, 2012, Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2, Dig Dis Sci, 57, 2846, 10.1007/s10620-012-2292-3 Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P Franke, 2008, Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility, Nat Genet, 40, 1319, 10.1038/ng.221 Franke, 2010, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci, Nat Genet, 42, 1118, 10.1038/ng.717 Glocker, 2009, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N Engl J Med, 361, 2033, 10.1056/NEJMoa0907206 Berg, 1996, Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses, J Clin Invest, 98, 1010, 10.1172/JCI118861 Spencer, 2002, Distinct inflammatory mechanisms mediate early versus late colitis in mice, Gastroenterology, 122, 94, 10.1053/gast.2002.30308 Spencer, 1998, The orphan receptor CRF2–4 is an essential subunit of the interleukin 10 receptor, J Exp Med, 187, 571, 10.1084/jem.187.4.571 Martins, 2006, Transcriptional repressor Blimp-1 regulates T cell homeostasis and function, Nat Immunol, 7, 457, 10.1038/ni1320 Roers, 2004, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation, J Exp Med, 200, 1289, 10.1084/jem.20041789 Rubtsov, 2008, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, 28, 546, 10.1016/j.immuni.2008.02.017 Rakoff-Nahoum, 2006, Role of toll-like receptors in spontaneous commensal-dependent colitis, Immunity, 25, 319, 10.1016/j.immuni.2006.06.010 Hoshi, 2012, MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice, Nat Commun, 3, 1120, 10.1038/ncomms2113 Narushima, 2003, Evidence for oxidative stress in NSAID-induced colitis in IL10−/− mice, Free Radic Biol Med, 34, 1153, 10.1016/S0891-5849(03)00065-0 Im, 2014, Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10−/− mice, Gastroenterology, 147, 667, 10.1053/j.gastro.2014.05.034 Zigmond, 2014, Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis, Immunity, 40, 720, 10.1016/j.immuni.2014.03.012 Shouval, 2014, Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, Immunity, 40, 706, 10.1016/j.immuni.2014.03.011 Velcich, 2002, Colorectal cancer in mice genetically deficient in the mucin Muc2, Science, 295, 1726, 10.1126/science.1069094 Van der Sluis, 2006, Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection, Gastroenterology, 131, 117, 10.1053/j.gastro.2006.04.020 An, 2007, Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans, J Exp Med, 204, 1417, 10.1084/jem.20061929 Fu, 2011, Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice, J Clin Invest, 121, 1657, 10.1172/JCI45538 Panwala, 1998, A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis, J Immunol, 161, 5733, 10.4049/jimmunol.161.10.5733 Resta-Lenert, 2005, Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a−/− mice, Am J Physiol Gastrointest Liver Physiol, 289, G153, 10.1152/ajpgi.00395.2004 Collett, 2005, Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction, Eur J Pharm Sci, 26, 386, 10.1016/j.ejps.2005.07.013 Powell, 2012, The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells, Immunity, 37, 674, 10.1016/j.immuni.2012.09.008 Nenci, 2007, Epithelial NEMO links innate immunity to chronic intestinal inflammation, Nature, 446, 557, 10.1038/nature05698 Zaph, 2007, Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis, Nature, 446, 552, 10.1038/nature05590 Matsumoto, 1998, Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain, Gut, 43, 71, 10.1136/gut.43.1.71 Kaser, 2008, XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease, Cell, 134, 743, 10.1016/j.cell.2008.07.021 Adolph, 2013, Paneth cells as a site of origin for intestinal inflammation, Nature, 503, 272, 10.1038/nature12599 Takeda, 1999, Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils, Immunity, 10, 39, 10.1016/S1074-7613(00)80005-9 Kobayashi, 2003, Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice, J Clin Invest, 111, 1297, 10.1172/JCI17085 Pickert, 2009, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing, J Exp Med, 206, 1465, 10.1084/jem.20082683 Watanabe, 1998, Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa, J Exp Med, 187, 389, 10.1084/jem.187.3.389 Totsuka, 2007, IL-7 Is essential for the development and the persistence of chronic colitis, J Immunol, 178, 4737, 10.4049/jimmunol.178.8.4737 Nemoto, 2007, Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis, Gastroenterology, 132, 176, 10.1053/j.gastro.2006.10.035 Nemoto, 2009, Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis, J Immunol, 183, 5059, 10.4049/jimmunol.0803684 Nemoto, 2011, Luminal CD4+ T cells penetrate gut epithelial monolayers and egress from lamina propria to blood circulation, Gastroenterology, 141, 2130, 10.1053/j.gastro.2011.08.035 Nemoto, 2013, Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells, Gut, 62, 1142, 10.1136/gutjnl-2012-302029